focusIR May 2024 Investor Webinar: Blue Whale, Kavango, Taseko Mines & CQS Natural Resources. Catch up with the webinar here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksZotefoams Regulatory News (ZTF)

Share Price Information for Zotefoams (ZTF)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 488.00
Bid: 490.00
Ask: 495.00
Change: 12.00 (2.52%)
Spread: 5.00 (1.02%)
Open: 478.00
High: 491.00
Low: 474.00
Prev. Close: 488.00
ZTF Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Full Year Trading Update

19 Jan 2023 07:00

RNS Number : 1870N
Zotefoams PLC
19 January 2023
 

Zotefoams plc

("Zotefoams" or "Group")

 

Full year trading update

Strong performance and record profits

 

19 January 2023 - Zotefoams, a world leader in cellular materials technology, today provides a trading update for the Group's financial year ended 31 December 2022 (unaudited).

 

The strong trading performance reported in the Group's update of 15 December 2022 continued through to the end of the year and, as a result, the Group expects to report full year revenue growth of 26%, to £127.4m (2021: £100.8m), which is ahead of current market expectations.

 

Full year trends for the specific Group's business units were as follows:

 

•

29% growth in High Performance Product (HPP) sales to £54.5m (2021: £42.3m):

- Footwear sales grew by 25%, with continued momentum from new products and projects, representing approximately 33% of Group revenue

- ZOTEK® fluoropolymer foam revenue increased by 48%, principally benefitting from the continued recovery of the aviation market

- T-FIT® technical insulation sales grew 48%, overcoming continued COVID-related challenges in our manufacturing facility in China

•

25% growth in AZOTE® polyolefin sales to £70.1m (2021: £56.2m):

- Good performance from all regions with pricing actions recovering input cost inflation

- Volume in line with the previous year, with increases experienced in most major geographical markets offsetting a 5% decline in continental Europe, primarily due to lower demand from the automotive segment

•

23% growth in MuCell Extrusion (MEL) sales to £2.8m (2021: £2.3m), with increasing interest in the Group's technology for polymer reduction. Development of the mono-material ReZorce® packaging is progressing well and is currently a significant focus of the team.

 

Profit before tax for the year is now expected to be not less than £12.0m (2021: £7.0m), which is ahead of current market expectations and represents a year-on-year increase of over 70%. This record profit figure is net of the segment loss in the MEL Business Unit increasing to £1.9m (2021: £0.7m), which reflects the continued investment in the development of ReZorce packaging technology.

 

The Group demonstrated strong cash generation, with the year-end leverage multiple (net debt to EBITDA) expected to reduce to approximately 1.16x (2021: 2.06x).

 

Notice of results

 

The Company expects to publish its preliminary results for the year ended 31 December 2022 on Tuesday 21 March 2023.

 

Commenting on the update David Stirling, Group CEO of Zotefoams, said: 

 

"We are delighted to close the year with very strong sales growth, delivering record profits and excellent cash generation. 2022 was characterised by uncertainty and our team has responded well in dealing with these challenges. The Group has delivered growth across all business units.

 

"We have also continued to invest in the development of ReZorce mono-material packaging which represents a significant commitment to new technology in the sustainability of consumer goods, in line with our own ESG and efficiency initiatives which remain a core focus.

 

"Whilst the shorter-term macroeconomic climate remains uncertain, we continue to monitor the evolving landscape closely and believe Zotefoams has a strong portfolio of opportunities, a clear strategy and is well positioned to deliver further growth."

 

Enquiries:

 

Zotefoams plc

+44 (0) 208 664 1600

David Stirling, Group CEO

Gary McGrath, Group CFO

IFC Advisory (Financial PR & IR)

+44 (0) 203 934 6630

Graham Herring

Tim Metcalfe

Zach Cohen

 

 

 

About Zotefoams plc

 

Zotefoams plc (LSE - ZTF) is a world leader in cellular materials technology delivering optimal material solutions for the benefit of society. Utilising a variety of unique manufacturing processes, including environmentally friendly nitrogen expansion for lightweight AZOTE® polyolefin and ZOTEK® high-performance foams, Zotefoams sells to diverse markets worldwide. Zotefoams uses its own cellular materials to manufacture T-FIT® advanced insulation for demanding industrial markets. Zotefoams also owns and licenses patented microcellular foam technology to reduce plastic use in extrusion applications and for ReZorce® mono-material recyclable barrier packaging.

 

Zotefoams is headquartered in Croydon, UK, with additional manufacturing sites in Kentucky, USA and Brzeg, Poland (foam manufacture), Oklahoma, USA (foam products manufacture and conversion), Massachusetts, USA, Stilling, Denmark (microcellular foam technology) and Jiangsu Province, China (T-FIT).

 

www.zotefoams.com

 

AZOTE®, ZOTEK®, ReZorce® and T-FIT® are registered trademarks of Zotefoams plc.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTKZGMMNRKGFZM
Date   Source Headline
16th Jun 20205:05 pmRNSHolding(s) in Company
12th Jun 20203:25 pmRNSDirector/PDMR Shareholding
8th Jun 20202:06 pmRNSResult of the 2020 Annual General Meeting
2nd Jun 20208:00 amRNSOperational and Trading Update
22nd May 202012:07 pmRNSSecond Price Monitoring Extn
22nd May 202012:02 pmRNSPrice Monitoring Extension
14th May 20203:48 pmRNSIssue of Equity
14th May 20203:15 pmRNSDirector/PDMR Shareholding
6th May 20207:00 amRNS2019 Annual Report and Notice of the 2020 AGM
28th Apr 20204:39 pmRNSDisclosure of rights attached to equity shares
22nd Apr 20203:51 pmRNSDirector/PDMR Shareholding
16th Apr 202012:39 pmRNSDirector/PDMR Shareholding
14th Apr 20202:41 pmRNSDirector/PDMR Shareholding
8th Apr 20204:19 pmRNSDirector/PDMR Shareholding
7th Apr 20207:00 amRNSPreliminary Results
1st Apr 20207:00 amRNSNotice of Results
31st Mar 202012:07 pmRNSSecond Price Monitoring Extn
31st Mar 202012:02 pmRNSPrice Monitoring Extension
24th Mar 20207:00 amRNS2019 Summary, COVID-19 and Current Trading Update
23rd Mar 20207:00 amRNSDelayed Preliminary Results
19th Mar 20208:40 amRNSDirectorate Change
17th Mar 20209:49 amRNSHolding(s) in Company
12th Mar 20204:11 pmRNSDirector/PDMR Shareholding
10th Mar 20204:30 pmRNSNotice of Results
27th Feb 20203:00 pmRNSDirector Declaration
12th Feb 20209:24 amRNSDirector/PDMR Shareholding
21st Jan 20207:00 amRNSYear-End Trading Update
16th Jan 20203:33 pmRNSHolding(s) in Company
13th Jan 20204:21 pmRNSDirector/PDMR Shareholding
27th Dec 20199:03 amRNSHolding(s) in Company
17th Dec 20199:34 amRNSDirector/PDMR Shareholding
13th Dec 20198:41 amRNSHolding(s) in Company
3rd Dec 20197:00 amRNSHolding(s) in Company
26th Nov 201910:39 amRNSHolding(s) in Company
13th Nov 20193:09 pmRNSDirector/PDMR Shareholding
15th Oct 20192:50 pmRNSNOTIFICATION OF TRANSACTIONS OF DIRECTORS/PDMRs
15th Oct 20199:48 amRNSNOTIFICATION OF TRANSACTIONS OF DIRECTORS/PDMRs
15th Oct 20197:00 amRNSDirector/PDMR Shareholding
11th Oct 20194:31 pmRNSHolding(s) in Company
9th Oct 20192:37 pmRNSDirector/PDMR Shareholding
9th Oct 20197:00 amRNSNew technology for recyclable packaging
8th Oct 20197:00 amRNSAppointment of Joint Broker
3rd Oct 20197:00 amRNSTrading Update
1st Oct 201911:47 amRNSDirector Declaration
16th Sep 20193:39 pmRNSDirector/PDMR Shareholding
6th Sep 201912:07 pmRNSSecond Price Monitoring Extn
6th Sep 201912:02 pmRNSPrice Monitoring Extension
27th Aug 201912:07 pmRNSSecond Price Monitoring Extn
27th Aug 201912:02 pmRNSPrice Monitoring Extension
21st Aug 201912:07 pmRNSSecond Price Monitoring Extn

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.